HUTCHMED (China) (HCM) Cash from Investing Activities (2018 - 2021)

HUTCHMED (China)'s (HCM) quarterly Cash from Investing Activities came in at -$315.9 million in Q2 2021, down 665.3% year-on-year from $55.9 million in Q2 2020, and down 297.41% on a QoQ basis from $160.0 million in Q1 2021.

HUTCHMED (China) (HCM) Cash from Investing Activities (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has 4 years of Cash from Investing Activities data on file, last reported at -$315.9 million in Q2 2021.

  • On a quarterly basis, Cash from Investing Activities fell 665.3% year-over-year to -$315.9 million in Q2 2021; TTM through Jun 2021 was -$295.0 million, a 281.98% decrease from a year earlier, with the FY2025 full-year figure at -$29.4 million, up 69.38% from the prior year.
  • Cash from Investing Activities for Q2 2021 stood at -$315.9 million, down from $160.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for HCM reached as high as $160.0 million in Q1 2021 and fell as low as -$315.9 million in Q2 2021.
  • Historically, Cash from Investing Activities has averaged -$11.0 million across 4 years, with a median of $19.0 million in 2019.
  • Across the five-year window, Cash from Investing Activities soared 299.29% in 2019 and sank 665.3% in 2021, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$15.3 million in 2018, then soared by 193.2% to $14.2 million in 2019, then slumped by 390.3% to -$41.3 million in 2020, then sank by 665.3% to -$315.9 million in 2021.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$315.9 million in Q2 2021, $160.0 million in Q1 2021, and -$41.3 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.69 Bn 87.82 Bn - -
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.57 Bn 30.63 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.52 Bn 23.46 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.08 Bn 20.93 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 22.43 Bn 22.43 Bn - -
7 Viatris 20.23 Bn 18.42 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.78 Bn 16.46 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.61 Bn 12.18 Bn 785.00 Mn -60.00 Mn
10 HUTCHMED (China) 9.57 Bn 9.39 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -315.92 Mn
Jun 30, 2021 -315.92 Mn
Mar 31, 2021 160.04 Mn
Mar 31, 2021 160.04 Mn
Jun 30, 2020 -41.28 Mn
Jun 30, 2020 -41.28 Mn
Mar 31, 2020 -97.84 Mn
Mar 31, 2020 -97.84 Mn
Dec 31, 2019 14.22 Mn
Dec 31, 2019 14.22 Mn
Sep 30, 2019 47.67 Mn
Sep 30, 2019 47.67 Mn
Jun 30, 2019 23.76 Mn
Jun 30, 2019 23.76 Mn
Mar 31, 2019 33.38 Mn
Mar 31, 2019 33.38 Mn
Dec 31, 2018 -15.26 Mn
Dec 31, 2018 -15.26 Mn
Sep 30, 2018 43.22 Mn
Sep 30, 2018 43.22 Mn